Nutromics
PrivateLast Round
Acceleration Round
Sep 2, 2025
Total Funding Raised
$18.13M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Nutromics operates in Healthcare & Life Sciences and is based in Melbourne. Its latest recorded funding round was an Acceleration Round in September 2025.
Nutromics is a healthtech company that develops a wearable diagnostic platform featuring DNA-based sensors and microneedles for continuous, real-time monitoring of molecular biomarkers and therapeutic drugs.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology, Health IoT, Sensors
Business Model
B2B
Customer Profile
Hardware Sales, Subscription SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Nutromics Comparables
Compare Nutromics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Adaptyx Biosciences | 84% | |
| Aptec Health | 79% | |
| KitechDx | 78% |
For institutional investors. Book with your work email.
Nutromics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Acceleration Round | Sep 2, 2025 | ||||
| Grant | Apr 27, 2024 | ||||
| VC Round | Jun 8, 2023 | ||||
| Seed | Sep 8, 2022 | ||||
| Grant | Sep 29, 2021 | ||||
Seed | Aug 27, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Nutromics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| MedTech Innovator | Grant |
| The Actuator | Pre Seed |
| Dexcom Ventures | Seed |
| Artesian | Pre Seed, Seed |
| VU Venture Partners | Seed |
| Australian Federal Government (Cooperative Research Centres Projects grant) | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors increased 114% MoM.
- Jul 24, 2026
Monthly visitors increased 43% MoM, reaching 2K.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- is_developingSep 18, 2026
Nutromics is developing a world-first wearable microneedle patch for real-time sepsis management with Professor Gooding, supported by $3 million in CRC-P funding.
- receives_financingSep 18, 2026
Nutromics and Professor Gooding recently secure $3M in CRC-P funding to further develop a wearable microneedle patch for real-time sepsis management.
- hiresSep 7, 2026
Nutromics appoints Professor Kevin W. Plaxco as Chief Scientific Officer in Australia on Sep 7th '26, with his strategic focus on extending its wearable DNA-based sensing platform to additional targets ahead of its first product launch in 2027.
For institutional investors. Book with your work email.
Nutromics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Nutromics's valuation, stock price, and market status.
Is Nutromics a public or private company?
Nutromics is a private company.
What is the current stock price of Nutromics?
Nutromics is a private company, so its shares have no public market price. Caplight tracks Nutromics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Nutromics worth (valuation)?
Valuation information for Nutromics is not publicly available.
Can I buy Nutromics stock?
Nutromics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Nutromics's last funding round?
Nutromics's most recent funding round was Acceleration Round on September 2, 2025.
Who are the main investors in Nutromics?
Key investors in Nutromics include The Actuator, Dexcom Ventures, Artesian, VU Venture Partners.
Will Nutromics IPO soon?
No public IPO plans have been announced for Nutromics.
How can I track Nutromics secondary market activity?
Caplight tracks bids, offers, and trades in Nutromics's shares on secondary markets.